rs759549373
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001377.3(DYNC2H1):c.10100G>A(p.Arg3367His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,612,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000034 ( 0 hom. )
Consequence
DYNC2H1
NM_001377.3 missense
NM_001377.3 missense
Scores
7
8
4
Clinical Significance
Conservation
PhyloP100: 9.99
Genes affected
DYNC2H1 (HGNC:2962): (dynein cytoplasmic 2 heavy chain 1) This gene encodes a large cytoplasmic dynein protein that is involved in retrograde transport in the cilium and has a role in intraflagellar transport, a process required for ciliary/flagellar assembly. Mutations in this gene cause a heterogeneous spectrum of conditions related to altered primary cilium function and often involve polydactyly, abnormal skeletogenesis, and polycystic kidneys. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.818
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYNC2H1 | NM_001080463.2 | c.10121G>A | p.Arg3374His | missense_variant | 67/90 | ENST00000650373.2 | NP_001073932.1 | |
DYNC2H1 | NM_001377.3 | c.10100G>A | p.Arg3367His | missense_variant | 66/89 | ENST00000375735.7 | NP_001368.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYNC2H1 | ENST00000650373.2 | c.10121G>A | p.Arg3374His | missense_variant | 67/90 | NM_001080463.2 | ENSP00000497174.1 | |||
DYNC2H1 | ENST00000375735.7 | c.10100G>A | p.Arg3367His | missense_variant | 66/89 | 1 | NM_001377.3 | ENSP00000364887.2 | ||
DYNC2H1 | ENST00000334267.11 | c.2205+118923G>A | intron_variant | 1 | ENSP00000334021.7 | |||||
ENSG00000285878 | ENST00000649070.1 | n.691-1038C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151964Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
151964
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000603 AC: 15AN: 248894Hom.: 0 AF XY: 0.0000741 AC XY: 10AN XY: 135024
GnomAD3 exomes
AF:
AC:
15
AN:
248894
Hom.:
AF XY:
AC XY:
10
AN XY:
135024
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461024Hom.: 0 Cov.: 32 AF XY: 0.0000399 AC XY: 29AN XY: 726776
GnomAD4 exome
AF:
AC:
50
AN:
1461024
Hom.:
Cov.:
32
AF XY:
AC XY:
29
AN XY:
726776
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151964Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74196
GnomAD4 genome
AF:
AC:
5
AN:
151964
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74196
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Asphyxiating thoracic dystrophy 3 Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jul 11, 2014 | This substitution is predicted to create a change of an arginine to a histidine at amino acid position 3374, NP_001073932.1(DYNC2H1): p.Arg3374His). The arginine at this position is highly conserved and is located in the ATP-binding dynein motor region D5. In-silico software predicts this variant to be disease-causing. this is a novel variant not present in disease or population databases. It was identified in a patient with clinical and radiographic features of JATD, and a second novel missense variant in the DYNC2H1 gene was present in trans. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM2_Supporting+PM3+PP4 - |
DYNC2H1-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 19, 2024 | The DYNC2H1 c.10121G>A variant is predicted to result in the amino acid substitution p.Arg3374His. This variant was observed in the confirmed compound heterozygous state in a patient with short ribs, bell-shaped chest, and skeletal dysplasia (Supplementary Table 1, Dillon et al. 2018. PubMed ID: 29453417). This variant is reported in 0.028% of alleles in individuals of Latino descent in gnomAD. In addition, another missense variant at the same residue resulting in a different amino acid change, p.Arg3374Cys, was reported along with a second pathogenic variant in a patient with asphyxiating thoracic dystrophy (Table S2, Zhang et al. 2018. PubMed ID: 29068549). Taken together, the c.10121G>A (p.Arg3374His) variant is interpreted as likely pathogenic. - |
Jeune thoracic dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 3374 of the DYNC2H1 protein (p.Arg3374His). This variant is present in population databases (rs759549373, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of Jeune syndrome (PMID: 26938784, 28832562, 29453417; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 369660). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DYNC2H1 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg3374 amino acid residue in DYNC2H1. Other variant(s) that disrupt this residue have been observed in individuals with DYNC2H1-related conditions (PMID: 29068549), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 26, 2023 | Variant summary: DYNC2H1 c.10121G>A (p.Arg3374His) results in a non-conservative amino acid change located in the Dynein heavy chain, tail (IPR013594) of the encoded protein sequence. Another missense variant (p.Arg3374Cys) affecting the same residue has been classified as pathogenic/likely pathogenic by ClinVar submitters. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6e-05 in 248894 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in DYNC2H1 causing Short-rib thoracic dysplasia (6e-05 vs 0.0025), allowing no conclusion about variant significance. c.10121G>A has been reported in the literature in an individual affected with features of Jeune asphyxiating thoracic dystrophy (Stark_2016), and the variant was found in trans with another DYNC2H1 variant that has been classified as likely pathogenic by ClinVar submitters. These data suggest the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26938784, 30190612). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. One submitter classified the variant as pathogenic, and one as likely benign. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Intellectual disability Benign:1
Likely benign, flagged submission | clinical testing | Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille | Jan 01, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;D;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;.;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;.;D
REVEL
Uncertain
Sift
Uncertain
D;.;.;D
Sift4G
Uncertain
D;.;.;D
Polyphen
D;D;D;D
Vest4
MVP
MPC
0.41
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at